Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCl) is an electrolyte supplement used to treat or prevent hypokalemia.
## Primary Indications
* Treatment of hypokalemia.
* Prevention of hypokalemia in patients at risk (e.g., those on diuretics, vomiting, diarrhea).
## Adult Dosing
* **Prevention:** 20 mEq (1.5 g KCl) orally once daily.
* **Treatment:**
* Mild hypokalemia (3.0-3.5 mEq/L): 20-40 mEq (1.5-3 g KCl) orally once daily, divided doses may be needed.
* Moderate hypokalemia (2.5-2.9 mEq/L): 40-100 mEq (3-7.5 g KCl) orally per day, divided every 6-12 hours.
* Severe hypokalemia (<2.5 mEq/L) or ECG changes: Intravenous (IV) administration is generally preferred. Dosing and infusion rate should be guided by clinical assessment, serum potassium level, and ECG findings. Maximum IV infusion rates typically range from 10-20 mEq/hour, but higher rates may be used in critical situations with continuous cardiac monitoring. A typical initial dose might be 40 mEq IV.
* **Maximum Oral Dose:** Generally not to exceed 200 mEq (15 g KCl) per day.
## Pediatric Dosing
* **Maintenance:** 1-2 mEq/kg/day orally, divided into 1-4 doses.
* **Treatment:** Dosing is highly individualized based on severity of hypokalemia, age, weight, and clinical status. IV administration may be necessary. Consult pediatric guidelines for specific IV dosing and infusion rates. A common IV starting dose might be 0.5-1 mEq/kg.
* **Maximum Doses:** Specific maximums should be determined by the treating physician.
## Dose Adjustments
* **Renal Impairment:** Use with extreme caution. Monitor potassium levels closely. May require significant dose reduction or avoidance.
* **Adrenal Insufficiency:** Use with caution.
## Contraindications
* Hyperkalemia.
* Conditions causing transient or persistent hyperkalemia (e.g., severe renal impairment, untreated Addison's disease, severe tissue trauma, extensive burns).
* Certain medications that can cause hyperkalemia (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics, aldosterone antagonists) in conjunction with potassium supplementation unless closely monitored.
## Adverse Effects
* **Most Common:** Gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain).
* **Serious:** Hyperkalemia (manifesting as muscle weakness, fatigue, paresthesias, cardiac arrhythmias, cardiac arrest), esophageal or gastric ulceration/perforation (especially with undissolved tablets or slow-release formulations taken without adequate fluid).
## Key Drug Interactions
* **ACE inhibitors, Angiotensin Receptor Blockers (ARBs), Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene), Aldosterone Antagonists (e.g., eplerenone), Trimethoprim:** Increased risk of hyperkalemia.
* **Corticosteroids:** May potentiate potassium loss.
* **Anticholinergics:** May increase risk of GI irritation with oral potassium.
## Monitoring
* Serum potassium levels (frequency depends on dose, route, and clinical status).
* Renal function (BUN, creatinine).
* ECG for signs of hyperkalemia.
* Signs and symptoms of hypokalemia and hyperkalemia.
## Clinical Pearls
* Oral potassium chloride should always be taken with sufficient fluid (at least 4-8 ounces) to minimize GI irritation and esophageal damage.
* Slow-release formulations are often better tolerated but may have inconsistent absorption.
* IV potassium is dangerous and must be administered with extreme caution and appropriate dilution and infusion rate, especially in patients with renal impairment or when using high concentrations. Continuous cardiac monitoring is essential for rapid IV infusions.
* Patients with severe vomiting or diarrhea may require more aggressive replacement.
* Renal function is a critical determinant of potassium excretion.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and guidelines before administering any medication. Dosing and management may vary based on individual patient factors and local protocols.